symbol,statement_type,period_end,line_item,value
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,90634624.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,90634624.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,3896186000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,4131152000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,18896863000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,23862587000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,6651177000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,18896863000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,167629000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,19899064000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,20934620000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,19899064000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,19899064000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,19445891000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,453173000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,453173000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,9164987000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,2594492000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,1000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1284041000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,1152245000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,116689000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,1035556000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,81178000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,6570495000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,171015000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,2978907000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,50940000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,2927967000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,117383000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Payables,2789753000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,11449000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,2778304000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,29064051000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,15842379000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,227466000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,432681000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,432681000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Equity Investment,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investments In Other Ventures Under Equity Method,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,1002201000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,984395000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,17806000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,14107018000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,14107018000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,3065818000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,11041200000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Properties,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,13221672000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,968230000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Inventory,5875794000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,10144000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,0.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,5754047000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,613457000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,546120000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,67337000.0
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
AARTIPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,0.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,90626008.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,90626008.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,2404686000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,2852540000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,16799845000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,20211427000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,6512519000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,16799845000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,211505000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,17570392000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,17570780000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,17570392000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,0.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,17570392000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,2284000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,10857668000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,4405754000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,453130000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,453130000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,8250659000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1306768000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,-1000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,60590000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1079200000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,166979000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,166591000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,388000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,60600000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,6943891000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,53700000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,2685561000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,44914000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,2640647000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,63137000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,63100000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Payables,4041098000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,256499000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,1430000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,0.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,3783169000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,25821051000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,12364641000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,-4000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,113290000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,311196000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,311196000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Equity Investment,56599000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investments In Other Ventures Under Equity Method,56599000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,770547000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,752741000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,17806000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,11054490000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-5368482000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,16422972000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,907573000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,10146900000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,12789010000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,1947005000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,779384000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,13456410000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,2000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,4271000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,734230000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Inventory,6428584000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,21406000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,2966470000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,1288730000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,2151978000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,121125000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,34428000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,5193444000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-22438000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,5215882000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,940326000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,703977000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,236349000.0
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,
AARTIPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,236349000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,90626008.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,90626008.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,2022149000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,2153128000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,15168563000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,17728227000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,5623825000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,15168563000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,9767000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,15584866000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,15586701000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,15584866000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,15584866000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,15131700000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,8893950000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,4405754000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,453130000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,453130000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,6855372000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,849138000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,100000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,53608000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,788376000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,7154000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,5319000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,1835000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,13196000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,6006234000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,27425000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,2145974000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,4448000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,2141526000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,54976000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,112143000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Payables,3641321000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,210427000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,723000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,35150000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,3395021000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,22440238000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,10810179000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,-1000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,94381000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,298630000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,298630000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Equity Investment,56619000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investments In Other Ventures Under Equity Method,56619000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,416303000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,398497000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,17806000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,9885724000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-4675670000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,14561394000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,646980000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,9238800000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,11609656000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,1635436000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,669322000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,11630059000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,75800000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,723000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,410564000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Inventory,6020410000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,26345000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,2653112000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,1402611000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,1938342000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,66211000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,0.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,4501038000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-25000000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,4526038000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,631113000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,509901000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,121212000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,128085000.0
AARTIPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,121212000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,90626008.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,90626008.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,2553504000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,3414005000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,13623319000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,17251016000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,4474825000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,13623319000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,27767000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,13864778000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,13870323000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,13864778000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,13864778000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,453130000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,7172365000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,4403254000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,2500000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,2500000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,6534218000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,727569000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,2000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,706699000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,20868000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,15323000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,5545000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,5806649000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,15231000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,3393137000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,12444000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,3380693000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,87834000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,89570000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Payables,2220877000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,75000000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,2145877000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,20398996000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,10117522000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,-3000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,85842000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,322255000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,322255000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Equity Investment,285522000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investments In Other Ventures Under Equity Method,285522000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,241459000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,223653000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,17806000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,9464222000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-4051070000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,9464222000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,1663341000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,7800881000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,9940805000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,1261297000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,649853000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,10281474000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,-15000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,0.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,41955000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Inventory,4754537000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,21945000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,1902178000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,900648000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,1929766000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,126801000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,758891000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,3766571000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,832734000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,832734000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,563062000.0
AARTIPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,269672000.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,-219000.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Payables,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Equity Investment,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investments In Other Ventures Under Equity Method,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,0.0
AARTIPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,2500000.0
